funding · NO · 14 MAR 2024bioMérieux invested NOK 115 million in SpinChip Diagnostics, becoming its second-largest shareholder with an expected 17–20% stake depending on further fundraising.SpinChip · EUR 10.0M · Strategic investmentProvenanceSourcesspinchip.nohttps://spinchip.no/2024/03/14/press-release-2/ActivityMore from SpinChipExit · 13 Jan · EUR 138.7MSpinChip agreed to be acquired in full by bioMérieux at a total enterprise value of NOK 1.624 billion.